The Communication and Dissemination Toolkit is in line with the scope of the Dissemination, Outreach and Communication Plan (D2.1). The toolkit has been developed in English. It includes the visual identity elements and indications on communication tools and channels to be used for dissemination and outreach.

Elements of this kit are project logo and brand, project PPT templates, templates for internal and external monthly electronic newsletters, elements for PRECISEU Platform (D2.4) and use of social media (mostly LinkedIn) to notify stakeholders about the project’s progress, calls and actions.

DOWNLOAD >

The PRECISEU website will be one of the project’s primary communication, dissemination, and outreach resources.

Its aim is to provide visitors with non-confidential information about the project and its activities, giving access to outcomes and linking to project-generated resources and outputs, as well as to the project`s social media and news.

It is conceived as a living tool, envisioned to grow during the first two years of the project with different uploads of information. The initial structure and approach included in this deliverable will be revised and adjusted to ensure alignment with the project strategy.

DOWNLOAD >

The deliverable is a comprehensive analysis of Hungary’s ecosystem in the context of personalized medicine, in particular regarding advanced therapies and with a particular focus on digital health innovation.

The primary objective is to evaluate the current state and prospects of country’s PM landscape, including the existing legal framework, innovation agenda, SWOT and potential synergies with other EU regions.

DOWNLOAD >

Europe aims to lead in deep-tech innovation by connecting talent with top companies and supporting breakthrough solutions. The Regional Innovation Valleys (RIVs) initiative strengthens regional innovation, especially in less advanced areas, by funding interregional projects aligned with EU priorities.

A key focus is healthcare, with Personalised Medicine (PM) central to improving quality of life for 448 million citizens. PM tailors treatments to individuals’ genetic profiles and supports prevention. The PRECISEU initiative accelerates PM adoption by linking regional ecosystems, improving health data use, supporting advanced therapies, and ensuring patient access—advancing the EU’s vision for a sustainable, innovative, and health-focused future.

The partners of PRECISEU identified the relevance of highlighting the challenges of an effective implementation of Personalised Medicine model across EU by aligning their actions to the events taking place during the Presidencies of the EU. At the moment of publication of this case study, Poland holds the presidency of the Council of the EU (for the second time) between 1 January 2025 and 30 June 2025.

DOWNLOAD >

The report of Task 4.1, “Assessing Readiness to EHDS”, presents a systematic approach for evaluating the technological, regulatory, organisational, and societal readiness of health data information ecosystems across PRECISEU-countries in Europe for integration into the European Health Data Space (EHDS), as part of the PRECISEU project’s Work Package 4 “Use of Health Data”.

To achieve this, the consortium developed the Maturity Grid Model (MGM), a standardised assessment tool with three levels of EHDS readiness that collects and compares essential EHDS requirements such as governance, technical infrastructure, health data readiness, resources, societal readiness, data privacy and security, access and control, unified market to EHR systems and innovation capacity. The assessment process is based on desk research and the analysis of existing reports and policy papers from the respective PRECISEU countries or regions, with all results transferred to the MGM and visualised in abridged versions in clear factsheets for each participating country or region.

This readiness framework provides a transparent and harmonised baseline for identifying strengths and gaps in EHDS implementation at the European level. The results serve as a foundation for further project activities, such as developing targeted recommendations for policymakers, informing joint interregional projects, supporting the design of interoperable health data infrastructures, and guiding capacity-building measures to enhance cross-border data sharing and the adoption of personalised medicine. Ultimately, Task 4.1 and the PRECISEU framework support the sustainable and effective realisation of the EHDS vision, enabling secure, innovative, and patient-centred healthcare across Europe.

DOWNLOAD >

EATRIS, together with European partners under the EU-funded PRECISEU project, is leading an initiative to map Advanced Therapy Medicinal Product (ATMP) capacities across Europe. The goal is to create a coordinated, data-driven infrastructure that ensures equitable access to advanced therapies such as gene, cell, and tissue-engineered treatments.

While ATMP science is advancing quickly, access remains uneven across EU countries due to differences in infrastructure, regulation, and clinical capacity. This mapping project establishes a sustainable, structured process—to be maintained by EATRIS and partners—that provides a comprehensive overview of Europe’s ATMP landscape, highlighting strengths and gaps in:

– Academic and translational research centres
– GMP manufacturing and processing facilities
– Clinical trial sites and hospitals
– National regulatory and logistics systems

In essence, the initiative aims to support better coordination and capacity building for ATMP development and delivery across Europe.

DOWNLOAD >

The PRECISEU project—PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope—aims to accelerate the development and equitable implementation of personalised medicine (PM) across Europe. This D6.1 Cross-Regional Report, led by Sahlgrenska Science Park, maps systemic barriers and promising practices in ten European regions/countries: Flanders (BE), Sofia (BG), Catalonia (ES), Baden-Württemberg (DE), Crete (EL), Emilia-Romagna (IT), Lithuania, the Netherlands, North East Romania, and Västra Götaland (SE).

DOWNLOAD >

This Handbook constitutes Deliverable 7.1 under Work Package 7 (Training and Cultural Change) of the PRECISEU project. It captures the design, implementation, and cumulative insights from the eight editions of the PRECISEU Personalised Medicine (PM) School, conducted across the project’s lifecycle. More than a record of events, this deliverable serves as a strategic and transferable knowledge resource—demonstrating how decentralised, regionally embedded training initiatives can advance a connected, inclusive, and innovation-driven European ecosystem for personalised medicine.

DOWNLOAD >

This Management and Guidelines document assembles all tools and workflows of the PRECISEU Best Practice Recognition to ensure its persistence throughout the overall runtime of PRECISEU. It is a deliverable to be available at M13 of the project in its first version. It may be updated and improved over time.

This document also serves as a core deliverable (D7.2) under Task 7.2 of the PRECISEU project. Its first version is submitted at Month 13 (M13) of the project and may be updated and refined over time in response to feedback from applicants, evaluators, and partner organizations. Future iterations may incorporate insights gained from the first recognition cycle, as well as the evolving needs of the project and its stakeholders.
This deliverable lays the foundation for interlinking the Best Practice Recognition with other project activities, including its integration into the PM School training programme (T7.3) and the Policy Biodesign workstream (T7.4). Recognised practices may be featured in training curricula, used as case studies in policy co-creation labs, or serve as models for regional implementation plans—amplifying their value and contributing to cross-WP synergy.

DOWNLOAD >

Biocat has devised a program inspired on Stanford Mussallem Center for Biodesign’s Policy Program. Biocat has already been implementing for years Stanford-based Design Thinking Methodology with its d·HEALTH Program, following Stanford University’s Biodesign methodology program for graduates.

The program is aimed for researchers and professionals who want to learn about entrepreneurship and innovation in healthcare. Several partners in the PRECISEU consortium have also expertise in Design Thinking methodologies to boost generation of cocreated ideas, products and services (Biovia, POP, CLustER, HLSCB, SSP…). Those will actively participate in some of the phases of the program, either in this first pilot edition in Barcelona or in the future editions in Flanders, Sofia or Emilia Romagna. Other partners involved in this task are Salut (Health Department, Government of Catalonia), ClustER, and POP (Platform of Patients’ Organisations). Those will be actively participating in the program in its different editions.

DOWNLOAD >